PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivity

Author:

Mosca Alessio1ORCID,Del Casale Antonio23ORCID,Borro Marina14ORCID,Gentile Giovanna14ORCID,Pomes Leda Marina14,Padovano Alessio13,Fiaschè Federica13,Pinzone Vito13,Rapinesi Chiara1,Zoppi Teodolinda13,Brugnoli Roberto13,Sani Gabriele5ORCID,Kotzalidis Georgios Demetrios1ORCID,Girardi Paolo13ORCID,Ferracuti Stefano6ORCID,Simmaco Maurizio14,Pompili Maurizio13ORCID

Affiliation:

1. Department of Neuroscience, Mental Health, & Sensory Organs (NESMOS), Faculty of Medicine & Psychology, Sapienza University, Rome, Italy

2. Department of Dynamic & Clinical Psychology, & Health Studies, Faculty of Medicine & Psychology, Sapienza University, Rome, Italy

3. Unit of Psychiatry, ‘Sant'Andrea’ University Hospital, Rome, Italy

4. Unit of Laboratory & Advanced Molecular Diagnostics, ‘Sant'Andrea’ University Hospital, Rome, Italy

5. Institute of Psychiatry & Psychology, Department of Geriatrics, Neuroscience & Orthopedics, Fondazione Policlinico Universitario IRCCS “A. Gemelli”, Università Cattolica del Sacro Cuore, Rome, Italy

6. Department of Human Neuroscience, Sapienza University; Unit of Risk Management, ‘Sant'Andrea’ University Hospital, Rome, Italy

Abstract

Background: Multiple chemical sensitivity (MCS) is a chronic condition with somatic, cognitive and affective symptoms that follow contact with chemical agents at usually non toxic concentrations. We aimed to assess the role of genetic polymorphisms involved in oxidative stress on anxiety and depression in MCS. Materials & methods: Our study investigated the CAT rs1001179, MPO rs2333227, PON1 rs662 and PON1 rs705379 polymorphisms in MCS. Results: The AG genotype of the PON1 rs662 and the TT and CT genotypes of the PON1 rs705379 were involved in anxiety and depression. Discussion: These results are in line with existing evidence of PON1 involvement in MCS and suggest a further role of this gene in the exhibition of anxiety and depression in this disease.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3